Analyticals Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.13 Cr
as on 04-07-2024
- Revenue 4.23%
(FY 2023)
- Profit 29.26%
(FY 2023)
- Ebitda 7.07%
(FY 2023)
- Net Worth 23.89%
(FY 2023)
- Total Assets -7.27%
(FY 2023)
About Analyticals Medical Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.13 Cr.
Latha Menon and Anil Ramachandran serve as directors at the Company.
- CIN/LLPIN
U52601MH2017PTC293070
- Company No.
293070
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Analyticals Medical Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Latha Menon  | Director | 27-Mar-2017 | Current |
| Anil Ramachandran | Director | 27-Mar-2017 | Current |
Financial Performance of Analyticals Medical Technologies.
Analyticals Medical Technologies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.23% increase. The company also saw a substantial improvement in profitability, with a 29.26% increase in profit. The company's net worth Soared by an impressive increase of 23.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Analyticals Medical Technologies?
In 2023, Analyticals Medical Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ar Photoniccs Private LimitedActive 2 years 4 monthsLatha Menon and Anil Ramachandran are mutual person
- Eravio Super Speciality Hospital & Resea Rch Centre LlpActive 3 years 10 months
Anil Ramachandran is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Nov 2022 | ₹3.13 Cr | Open |
How Many Employees Work at Analyticals Medical Technologies?
Unlock and access historical data on people associated with Analyticals Medical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Analyticals Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Analyticals Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
